Abiopharma

Incorporated in 2011, Singapore Institute of Advanced Medicine Holdings Ltd. (the "Company" and together with its subsidiaries, the "Group") is a healthcare service provider using advanced technology for early and accurate diagnosis and offering appropriate treatments to achieve better outcomes and quality of life for its patients. The Group’s services cater to a wide spectrum of diseases and health conditions including, but not limited to, cancer, neurodegenerative and cardiovascular disease detection, and treatment. The Group is primarily engaged in the following key business segments: (i) Medical Diagnostics and Treatments; and (ii) Radiation Therapy and Medical Oncology Services. The Company’s goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer. The Group aims to do this by bringing together a dedicated team of professionals and experts from the industry who will work with the Group to seek solutions for the diagnosis and treatment of cancer patients and improve their quality of life.

Additional info from SGX:

Incorporated in 2011, Singapore Institute of Advanced Medicine Holdings Ltd. (the "Company" and together with its subsidiaries, the "Group") is a healthcare service provider using advanced technology for early and accurate diagnosis and offering appropriate treatments to achieve better outcomes and quality of life for its patients. The Group’s services cater to a wide spectrum of diseases and health conditions including, but not limited to, cancer, neurodegenerative and cardiovascular disease detection, and treatment. The Group is primarily engaged in the following key business segments: (i) Medical Diagnostics and Treatments; and (ii) Radiation Therapy and Medical Oncology Services. The Company’s goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer. The Group aims to do this by bringing together a dedicated team of professionals and experts from the industry who will work with the Group to seek solutions for the diagnosis and treatment of cancer patients and improve their quality of life.